MiNA Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
84 Wood Ln, London, Greater London, W12 ...Phone Number
+44 2088116700Website
www.minatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About MiNA Therapeutics
MiNA Therapeutics is a London-based clinical-stage biotechnology company specializing in RNA activation therapeutics with an initial focus on liver cancer. The company was established in 2008.Explore more
MiNA Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MiNA Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if MiNA Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at MiNA Therapeutics
Funding: Get notified immidiatlly once MiNA Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when MiNA Therapeutics launches new products
Click to see if MiNA Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
MiNA Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on MiNA Therapeutics recently announced quarterly report
Check if MiNA Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at MiNA Therapeutics
Find 3 more new buyers
Compare Similar Companies to MiNA Therapeutics
Compare insights from companies similar to MiNA Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MiNA Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MiNA Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MiNA Therapeutics.
MiNA Therapeutics financials insights
Gather financial insights about MiNA Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$45.2M
2020
Series A
$30M
2021
Private Equity
$15M
MiNA Therapeutics Tech Stack
A closer look at the technologies used by MiNA Therapeutics
See more technologies
Most Recent Scoops
Promotion
Executive Move
Executive Moves, Promotion
Executive Move
Executive Moves, Board of Directors
Event
Events
Event
Events
New Hire
Executive Move
MiNA Therapeutics News & Media
MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting
LONDON--(BUSINESS WIRE)--MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, today presented new pre-clinical data for its lead RNA activation program for the treatment of sickle cell disease, which demonstrated best-in-class activity and safety. The data shared at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego will also be highlighted at a poster walk session on December 9, 2024, at 12:30 pm PST. MTL-HBG is an RNAa medicine designedNS Pharma Announces Research Alliance with MiNA Therapeutics to Develop Therapies for Rare Diseases of the Central Nervous System
PARAMUS, N.J., April 4, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma) announced that its parent company, Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) – headquartered in Kyoto, Japan, entered into a joint research agreement with MiNA Therapeutics – headquartered in London, United...MiNA Therapeutics Enters Research Collaboration with Nippon Shinyaku to Develop RNAa Therapeutics Targeting Rare Neurodegenerative Diseases
LONDON--(BUSINESS WIRE)--MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a research collaboration and licensing agreement option with Nippon Shinyaku Co., Ltd. (Nippon Shinyaku; Headquarters: Kyoto; President: Toru Nakai), an innovation-driven Japanese-based pharmaceutical company focused on disease areas of high unmet medical need. The collaboration will allow for the discovery, and potential development and commercialization of RNAa therapeutic candMiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia’s Delivery of Nucleic Acid Therapeutics Conference
LONDON--(BUSINESS WIRE)--MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, announced today that it will present new pre-clinical data for its lead RNA activation program targeting fetal hemoglobin (HbF) at the Keystone Symposia’s Delivery of Nucleic Acid Therapeutics Conference in Banff, Alberta, Canada. Pre-clinical studies confirmed in vivo delivery of MiNA’s RNAa therapeutics to erythroid progenitor cells in bone marrow at levels that are clinically meaningf
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding MiNA Therapeutics
Sign Up For FreeTo access detailed company insights
MiNA Therapeutics is a London-based clinical-stage biotechnology company specializing in RNA activation therapeutics with an initial focus on liver cancer. The company was established in 2008.... Read More
